Teva settles multibillion-dollar drug kickback case ahead of trial - Reuters

archive.today
webpage capture

Saved from

no other snapshots from this url |

3 Aug 2020 07:06:59 UTC

All snapshots | from host www.reuters.com
Webpage Screenshot
share download .zip report bug or abuse donate

United States
Westlaw News
August 15, 2019 / 8:32 PM / a year ago

# Teva settles multibillion-dollar drug kickback case ahead of trial

Nate Raymond
1 Min Read

Teva Pharmaceutical Industries Ltd has agreed on the eve of trial to settle a multibillion-dollar whistleblower lawsuit alleging it paid doctors kickbacks to prescribe its Parkinson’s disease drug Azilect and multiple sclerosis treatment Copaxone.
Teva late on Wednesday said it had reached an agreement-in-principle to resolve a lawsuit in Manhattan federal court by two ex-employees alleging the drugmaker paid doctors to act as speakers at events in order to sway them to prescribe its drugs.
To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/31DI6aw
Our Standards: The Thomson Reuters Trust Principles.

##### Trending

- ###### Exclusive: TikTok's Chinese owner offers to forego stake to clinch U.S. deal - sources

- ###### Samsung Electronics to halt production at its last computer factory in China

- ###### At least 40 infected with COVID-19 on Norway cruises amid scramble to trace passengers

- ###### Samsung crafts India comeback as anti-China wave surges

- ###### Thousands march in Berlin against coronavirus curbs

0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%